Pancrelipase

In the US, Pancrelipase (pancrelipase systemic) is a member of the drug class digestive enzymes and is used to treat Chronic Pancreatitis, Cystic Fibrosis and Pancreatic Exocrine Dysfunction.

US matches:

• Pancrelipase


• Pancrelipase Capsules


• Pancrelipase Capsules (Enteric-Coated)

Scheme

USAN

CAS registry number (Chemical Abstracts Service)

0053608-75-6

Therapeutic Category

Pancreatic enzyme

Chemical Name

A concentrate of pancreatic enzymes standardized for lipase content

Foreign Name

• Pancrelipase (German)

Generic Names

• Pancrelipase (OS: USAN)
• Containing enzymes (IS: prinicpally lipase with amylase and protease)
• Pancrelipase (PH: USP 32)

Brand Names

• Cotazym ECS
  Pharmaco, New Zealand



• Cotazym-S Forte
  Organon, Australia



• Creon
  Solvay, Italy; Solvay, United States



• DMH
  Axcan, Canada



• Ku-Zyme
  Schwarz, United States



• Lipram
  Global, United States



• Pancrease
  Janssen, Costa Rica; Janssen, Dominican Republic; Janssen, Guatemala; Janssen, Honduras; Janssen, Iceland; Janssen, Nicaragua; Janssen, Panama; Janssen, El Salvador; Janssen-Ortho Inc., Canada; McNeil, United States; Ortho-McNeil, Israel; Ortho-McNeil, United States



• Pancrecarb
  Digestive, United States



• Pancrelipase
  Global, United States



• Pancrex
  Mipharm, Italy



• Pangestyme
  Ethex, United States



• Panokase
  Breckenridge, United States



• Panzytrat
  Pharmaco, New Zealand



• Ultrase
  Axcan, Canada; Axcan, United States



• Viokase
  Axcan, Canada; Axcan, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.